University of Thessaly (UTH)
Μελέτη του σηματοδοτικού μονοπατιού BAFF/APRIL στην οξεία λεμφοβλαστική λευχαιμία
Abstract
dc:descriptionBAFF and APRIL are master regulators of survival, maturation and homeostasis of normal developing B-cells, by interacting with three cognate receptors, BAFFR, TACI and BCMA. Despite the lack of a functional role of BAFF/APRIL system during normal early B-cell development, previous studies indicated a possible contribution of these molecules in the pathogenesis of B-lineage acute lymphoblastic leukemia (B-ALL), a heterogeneous disease arising from the malignant transformation of progenitor B-cells. Herein, we evaluated the expression of this system in B-ALL and its involvement in spontaneous and drug-induced apoptosis of B-lymphoblasts, taking into consideration the distinct disease subtypes. The mRNA expression of BAFF, APRIL and their receptors was evaluated by RT-PCR in 70 patients with ALL (children and adults), while receptors’ protein expression was measured by flow cytometry. According to our results, we performed ChIP experiments in the E2A-PBX1+ pre-B-ALL cell line 697 and we investigated binding of the E2A-PBX1 chimeric transcription factor in possible regulatory regions of BAFFR gene. The functionality of BAFFR was assessed by treating B-lymphoblasts with exogenous BAFF and checking the NF-κΒ2 activation by Western blot. We also evaluated the contribution of BAFF/BAFFR crosstalk in spontaneous and drug-induced apoptosis in B-lymphoblasts. Last but not least, we checked the activation of signaling pathways (NF-κΒ2, PI3K & NF-κΒ1) in BAFF/dexamethasone treated cells. We found that BAFFR is the most predominant aberrantly expressed receptor in B-ALL at mRNA and protein level and its expression, along with those of BCMA and APRIL, was correlated with the maturation stage of B-lymphoblasts. Moreover, the binding of the E2A-PBX1 chimeric protein to BAFFR promoter, suggests a potential mechanism explaining the increased BAFFR expression observed in a proportion of pre-B-ALL patients carrying the E2A-PBX1 translocation. Despite its aberrant expression in B-ALL, binding of BAFF to BAFFR activates the NF-κΒ2, the major signaling pathway downstream of BAFF/BAFFR crosstalk, indicating that the receptor is functional, while it induces BAFFR processing by cell membrane, regulating its levels. However, we found that BAFF-treatment increased the spontaneous cell death of BAFFR+ B-lymphoblasts in patients with BCR-ABL+ pre-B-ALL. This finding was strengthened by the fact that BAFF enhanced the glucocorticoid-induced apoptosis in 697 cells, without changing the dynamics of these cells in activating NF-κΒ2 and in BAFFR processing. These data suggest a disease-subtype specific role of BAFF/APRIL system in B-ALL pathogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sevdali, Eirini
- Σεβδαλή, Ειρήνη
Subjects
dc:subject × 22- Β-οξεία λεμφοβλαστική λευχαιμία
- BAFF/APRIL σύστημα
- Υποδοχέας BAFFR
- Συνδέτης BAFF
- Μεταγραφικός παράγοντας E2A-PBX1
- Εναλλακτική οδός του NF-κB2
- Γλυκοκορτικοειδή
- Απόπτωση
- Χρωμοσωμική μετατόπιση BCR-ABL
- B-cell acute lymphoblastic leukemia
- BAFF/APRIL system
- BAFFR receptor
- BAFF ligand
- Transcription factor E2A-PBX1
- Alternative pathway of NF-κB2
- Glucocorticoids
- Apoptosis
- Chromosomal translocation BCR-ABL
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42864